Beta Bionics (BBNX) Change in Account Payables (2024 - 2026)

Beta Bionics has disclosed Change in Account Payables across 3 years of filings, most recently posting -$3.3 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$3.3 million, down 3336.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 212.9% YoY), and the FY2025 annual result was $2.1 million, up 38.48% from the prior year.
• Change in Account Payables came in at -$3.3 million for Q1 2026 at Beta Bionics, down from $527000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2025 to a low of -$3.3 million in Q1 2026.
• The 3-year median for Change in Account Payables is $410000.0 (2024), against an average of $31111.1.
• Across the five-year window, Change in Account Payables soared 963.93% in 2025 and slumped 3336.08% in 2026, its largest moves.
• Beta Bionics' Change in Account Payables stood at -$61000.0 in 2024, then jumped by 963.93% to $527000.0 in 2025, then tumbled by 732.45% to -$3.3 million in 2026.
• The last three Change in Account Payables figures came in at -$3.3 million (Q1 2026), $527000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.